Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Vanta Bioscience Limited, is an unlisted public company incorporated on 29 April, 2016. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 7.50 cr and the total paid-up capital is INR 6.31 cr.
Vanta Bioscience Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2020. It's EBITDA has increased by 32.07% over the previous year. At the same time, it's book networth has increased by 5.37%.
Read more
** All rupee values in INR lacs. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Yogeswara Rao Danda | 00694803 | 6 years |
Managing Director | Dopesh Raja Mulakala
Shareholder
|
01176660 | 9 years |
Director | Mohan Krishna Mulakala
Shareholder
|
01448535 | 9 years |
Director | Padmanabhuni Venkata Appaji | 02614167 | 8 years |
Whole-time Director | Vyasmurti Madhavrao Shingatgeri
Shareholder
|
07728757 | 8 years |
Director | Gonuguntla Kathyayani | 07824881 | 8 years |
Kmp | Vidisha Vimal Hingu | <HIDDEN> | 3 years |
Kmp | Venkata Sathya Murali Dokka | <HIDDEN> | 4 years |
Kmp | Sangeetha Padam Choudhary | <HIDDEN> | 1 years |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 19.3 cr
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
ASSOCIATION FOR SCIENTIFIC PURSUITS FOR INNOVATIVE RESEARCH ENTERPRISES |
Active
|
0.0 | 1 | Telangana |
NUTRIHUB TECHNOLOGY BUSINESS INCUBATOR STARTUPS CONFEDERATION |
Active
|
0.0 | 1 | Telangana |
SARVOTHAM REMEDIES LIMITED |
Active
|
57.0 L | 1 | Telangana |
SHREE COSMETICS LIMITED |
Active
|
4.0 Cr | 2 | Delhi |
VANTA CLINICAL RESEARCH LIMITED |
Active
|
3.0 Cr | 1 | Telangana |
CEBIS INDIA LIMITED |
Active
|
8.3 Cr | 1 | Telangana |
SARVOTHAM SOLUTIONS LIMITED |
Active
|
22.7 L | 2 | Telangana |
Sarvotham Hexis LLP |
Active
|
1.0 L | 1 | ng |
SARVOTHAM CARE LIMITED |
Active
|
25.0 Cr | 2 | Telangana |
SPECIFIC LABORATORIES PVT. LTD. |
Active
|
4.1 L | 1 | Telangana |
SAI MED PHARMA SYSTEMS PRIVATE LIMITED |
Active
|
1.5 Cr | 1 | Telangana |
MEENAXY LIFE SCIENCES LIMITED |
Strike Off
|
5.0 L | 1 | Telangana |
VASUDHA PHARMA CHEM LIMITED |
Active
|
35.0 Cr | 2 | |
NUUTJOB LIMITED |
Active
|
98.0 L | 1 | Gujarat |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
VANTA CLINICAL RESEARCH LIMITED | Telangana | 2018 | ₹ 3.0 Cr |
Read more
The incorporation date of VANTA BIOSCIENCE LIMITED is 29 April, 2016
The authorized share capital of VANTA BIOSCIENCE LIMITED is INR ₹ 7.5 Cr.
The paid-up capital of VANTA BIOSCIENCE LIMITED is INR ₹ 6.3 Cr.
The registered address of VANTA BIOSCIENCE LIMITED is NO.02/G/308/G NO.3/FF/SF/1-20-248 UMAJAY COMPLEX RASOOLPURA SECUNDERABAD Hyderabad Telangana - 500003
The CIN number of VANTA BIOSCIENCE LIMITED is L74999TG2016PLC109280.